TNM005
/ Guangzhou Trinomab Biotechnology
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
July 11, 2024
A Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Profile of TNM005 in Healthy Adult Subjectsy
(clinicaltrials.gov)
- P1 | N=48 | Recruiting | Sponsor: Zhuhai Trinomab Pharmaceutical Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Varicella Zoster
October 05, 2023
A Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Profile of TNM005 in Healthy Adult Subjectsy
(clinicaltrials.gov)
- P1 | N=48 | Not yet recruiting | Sponsor: Zhuhai Trinomab Pharmaceutical Co., Ltd.
New P1 trial • Varicella Zoster
1 to 2
Of
2
Go to page
1